Bottom line
XLV vs HCPIX: the short answer
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and HCPIX (Health Care Ultrasector Profund) share a meaningful slice of their top holdings — about 70% by weight.
XLV is cheaper at 0.08% vs 1.76% — a difference of $168 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +6.4% for HCPIX (reporting dates differ).
Updated Nov 19, 2026
XLV vs HCPIX side by side
| XLV | HCPIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | SPDR (State Street) | ProShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.08% | 1.76% |
| Annual cost per $10k | $8 | $176 |
| 10-yr cost on $10k (prospectus) | $103 | $2,073 |
| Max front load | None | — |
| 12b-1 fee | 0.02% | 0% |
| 1-yr return | +14.5% | −1.4% |
| 5-yr return (annualized) | +8.1% | +6.4% |
| 10-yr return (annualized) | +9.8% | +9.2% |
| Best quarter | +14.5% | +22.0% |
| Worst quarter | −12.7% | −21.0% |
| Net assets (fund) | $40.6B | $12.1M |
| Number of holdings | 65 | 69 |
| Portfolio turnover | 2% | 99% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | XLV | HCPIX | Difference |
|---|---|---|---|
| 2024 | +2.5% | −1.4% | +3.9% |
| 2023 | +2.0% | −1.3% | +3.3% |
| 2022 | −2.1% | −10.6% | +8.5% |
| 2021 | +25.9% | +33.9% | −8.0% |
| 2020 | +13.3% | +16.9% | −3.6% |
| 2019 | +20.7% | +28.4% | −7.8% |
| 2018 | +6.3% | +5.0% | +1.3% |
| 2017 | +21.7% | +32.2% | −10.5% |
| 2016 | −2.8% | −6.5% | +3.7% |
Source: Fund prospectus bar charts
Holdings overlap
18 of XLV's top 25 holdings also appear in HCPIX's top 25.
| Holding | XLV | HCPIX |
|---|---|---|
| Eli Lilly & Co | 16.51% | 11.83% |
| Johnson & Johnson | 10.64% | 8.03% |
| AbbVie Inc | 7.74% | 5.77% |
| UnitedHealth Group Inc | 6.57% | 4.90% |
| Merck & Co Inc | 5.52% | 4.19% |
| Amgen Inc | 3.40% | 2.71% |
| Thermo Fisher Scientific Inc | 3.24% | 2.78% |
| Abbott Laboratories | 2.75% | 2.40% |
| Gilead Sciences Inc | 2.73% | 2.10% |
| Intuitive Surgical Inc | 2.45% | 1.63% |
| Pfizer Inc | 2.39% | 1.86% |
| CVS Health Corp | 2.30% | 1.73% |
| Vertex Pharmaceuticals Inc | 2.19% | 1.57% |
| Danaher Corp | 2.09% | 1.60% |
| Bristol-Myers Squibb Co | 2.05% | 1.74% |
Source: SEC Form N-PORT
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
HCPIX top 10
- Eli Lilly & Company — 11.83%
- Johnson & Johnson — 8.03%
- N/a — 6.45%
- Abbvie Inc — 5.77%
- N/a — 4.97%
- Unitedhealth Group Inc — 4.90%
- Merck & Company Inc — 4.19%
- N/a — 3.96%
- N/a — 3.96%
- N/a — 3.11%
FAQ
What is the difference between XLV and HCPIX?
Which is cheaper, XLV or HCPIX?
Should I own both XLV and HCPIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.